Investigating the potential of oncolytic viruses for cancer treatment via MSC delivery
Abstract Mesenchymal stem cells (MSCs) have attracted considerable interest as a promising approach for cancer treatment due to their ability to undergo tumor-trophic migration. MSCs possess the unique ability to selectively migrate to tumors, making them an excellent candidate for targeted delivery...
Main Authors: | Hadi Esmaeili Gouvarchin Ghaleh, Gazal Vakilzadeh, Ali Zahiri, Mahdieh Farzanehpour |
---|---|
Format: | Article |
Language: | English |
Published: |
BMC
2023-09-01
|
Series: | Cell Communication and Signaling |
Subjects: | |
Online Access: | https://doi.org/10.1186/s12964-023-01232-y |
Similar Items
-
Editorial: Recent advances in oncolytic virus therapy for brain tumors
by: Fatemeh Sana Askari, et al.
Published: (2023-08-01) -
Oncolytic vaccinia virus and cancer immunotherapy
by: Lihua Xu, et al.
Published: (2024-01-01) -
Simultaneous Tumor and Stroma Targeting by Oncolytic Viruses
by: Anne Everts, et al.
Published: (2020-11-01) -
Combination Immunotherapy Using Oncolytic Virus for the Treatment of Advanced Solid Tumors
by: Chang-Myung Oh, et al.
Published: (2020-10-01) -
Remodeling the tumor immune microenvironment with oncolytic viruses expressing miRNAs
by: Guillaume St-Cyr, et al.
Published: (2023-01-01)